Skip to main content
MLEC
NASDAQ Manufacturing

Moolec Science SA Faces Winding Up Petition Over $2.3M Legal Fee Dispute

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$7.66
Mkt Cap
$5.39M
52W Low
$3.077
52W High
$82.65
52W Position info
149% above low
Off High info
91% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

MLEC has more than doubled off its 52-week low of $3.077 on light trading volume (0.1× avg).

Summary

Moolec Science SA received a winding up petition from Linklaters LLP over $2.3 million in disputed legal fees, with a hearing scheduled for November 3, 2026. The company disputes the claim and will contest the petition, but the filing blocks a planned share issuance and adds to existing going concern risks.


Key Events · Legal and Risk Events · MLEC

  • Winding Up Petition Filed

    On July 8, 2026, Linklaters LLP filed a petition to wind up Moolec Science SA, seeking the appointment of joint liquidators over an alleged $2.3 million legal fee debt.

  • Company Disputes Claim

    Moolec disputes the petition, calling it an abuse of process, and notes that the fees relate to services under former management; it intends to seek dismissal and costs.

  • Hearing Set for November 3, 2026

    The Grand Court of the Cayman Islands scheduled the hearing for November 3, 2026, leaving the company under threat of liquidation for several months.

  • Share Issuance Blocked

    The petition prevents Moolec from issuing the Returning Holdback Amount shares under its business combination agreement, impacting shareholders entitled to those shares.


Analysis · MLEC · Manufacturing

A winding up petition poses an existential threat — if granted, the company would be liquidated. Filed by former legal counsel Linklaters LLP, the petition claims $2.3 million in unpaid fees for services rendered under prior management. Moolec disputes the debt and intends to vigorously contest the petition, but the mere filing freezes the company's ability to issue shares under its business combination agreement and signals severe distress. This development arrives just two months after the company disclosed a going concern warning and regained Nasdaq compliance, underscoring its fragile financial health. The hearing is set for November 3, 2026, leaving months of uncertainty.

At the time of this filing, MLEC was trading at $7.66 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $5.4M. The 52-week trading range was $3.08 to $82.65. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MLEC - Latest Insights

MLEC
Jul 13, 2026, 7:16 PM EDT
Filing Type: 6-K
Importance Score:
9
MLEC
Jun 02, 2026, 8:45 AM EDT
Filing Type: 6-K
Importance Score:
8
MLEC
May 14, 2026, 9:00 AM EDT
Source: Access Newswire
Importance Score:
7
MLEC
May 13, 2026, 9:17 PM EDT
Filing Type: 6-K
Importance Score:
9
MLEC
May 13, 2026, 5:19 PM EDT
Filing Type: 6-K
Importance Score:
8
MLEC
Apr 29, 2026, 9:04 AM EDT
Source: Access Newswire
Importance Score:
8
MLEC
Apr 07, 2026, 8:07 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
MLEC
Apr 07, 2026, 8:00 AM EDT
Source: Access Newswire
Importance Score:
8
MLEC
Apr 02, 2026, 2:46 PM EDT
Filing Type: 6-K
Importance Score:
9
MLEC
Jan 30, 2026, 4:41 PM EST
Filing Type: 6-K
Importance Score:
9